cerrar
Tagged with Novartis

Avinash Potnis – Managing Director, Novartis Pharma Turkey
Avinash Potnis of Novartis Turkey discusses potential solutions to the country’s access and pricing dilemma which has raised concerns of system…

Mexico Pharma News: Bayer Targets Cancer; Novartis Gets…
The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion strategy as well as updates on the…

Georg Schroeckenfuchs of Novartis: ‘Shooting for the Moon’ in…
33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the vast Middle East & Africa (MEA) region for Swiss behemoth Novartis,…

Georg Schroeckenfuchs – President MEA and Head Gulf &…
Georg Schroeckenfuchs, Novartis’ president MEA and head of its Gulf and Saudi Country Group, explains how the company’s objectives are aligned…

What Switzerland Means to Novartis & Roche
The Novartis and Roche names are synonymous with Swiss pharmaceutical innovation. But for these two Basel-based global behemoths, what value does…

Top 10 Pharma Companies in Canada Ranking 2020
The Top 10 companies in the Canadian pharma market for 2020, ranked by revenues in USD billions. J&J takes the top spot with USD 3.46 billion,…

APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year and with deaths caused by cancer expected to increase by 36 percent by…

Innovative Pharma Doubles Down on IP with New Pact
On World Intellectual Property (IP) Day 2021, the innovative biopharmaceutical industry came together to launch a new initiative foregrounding the…

Vincent Gruntz – General Manager Oncology, Novartis Pharma…
Vincent Gruntz looks at the market dynamics for oncology in Switzerland, where an increasingly cost-conscious approach is being taken to reimbursement…

Kevin Zou – Head of Oncology Asia Pacific & Country…
Kevin Zou highlights Novartis Oncology’s footprint and priorities in the diverse Asia-Pacific region, the challenges of introducing cutting-edge…

Italy: Stevanato’s $5 bn valuation; Zolgensma Approval; Sputnik…
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine contracts, glass vial manufacturer…

China: New Year, New Round of Drug Price Cuts
Since China first announced its ground-breaking volume-based procurement (VBP) pilot program to reduce drug expenditures in 2018, the world’s…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here